000 01731 a2200421 4500
005 20250515220537.0
264 0 _c20100713
008 201007s 0 0 eng d
022 _a1521-0103
024 7 _a10.1124/jpet.110.165498
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTan, Sandra Min-Li
245 0 0 _aIdentification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
_h[electronic resource]
260 _bThe Journal of pharmacology and experimental therapeutics
_cJul 2010
300 _a285-93 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents, Phytogenic
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBlotting, Western
650 0 4 _aCarcinoma, Hepatocellular
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aEscin
_xpharmacology
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aJanus Kinase 2
_xantagonists & inhibitors
650 0 4 _aLiver Neoplasms
650 0 4 _aPhosphorylation
650 0 4 _aSTAT3 Transcription Factor
_xantagonists & inhibitors
650 0 4 _aSignal Transduction
_xdrug effects
700 1 _aLi, Feng
700 1 _aRajendran, Peramaiyan
700 1 _aKumar, Alan Prem
700 1 _aHui, Kam M
700 1 _aSethi, Gautam
773 0 _tThe Journal of pharmacology and experimental therapeutics
_gvol. 334
_gno. 1
_gp. 285-93
856 4 0 _uhttps://doi.org/10.1124/jpet.110.165498
_zAvailable from publisher's website
999 _c19738039
_d19738039